Professor Chris Fegan
Professor Fegan is a recently retired clinical haematologist and Professor Emeritus at Cardiff University. He was the first haematopoietic stem cell transplant research fellow in Wales which is also where he undertook most of his specialist haematology training. His first consultant haematology post was in Birmingham but he returned to Cardiff in 2005 and was awarded a professorship in 2012. Professor Fegan is also the former Director of Research and Development for Cardiff and Vale University Health Board and Cardiff Medical School and co-founder and Chief Medical Officer at Telonostix.
He was a member of the Executive Board of the British Society for eight years including six years as treasurer. He chairs the Cancer Research Wales Scientific Committee. Chris’ main research interests were in chronic lymphocytic leukaemia, prognostic markers, new drug developments and clinical trials including first in human studies. Chris has over 200 research publications.
![](https://cdn.cancerresearch.wales/uploads/_large_square/1.jpg?v=1721236026)